US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 64.490
  • -0.200-0.31%
Close Nov 8 16:00 ET
  • 64.670
  • +0.180+0.28%
Post 20:01 ET
199.96BMarket Cap31.31P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AstraZeneca Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
13.08B
+13.86%
EPS
0.77
+73.46%
Analyst Rating
Strong Buy

Nov 8, 2024

AstraZeneca Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 13.726B--
Nov 12, 20242024/Q3-- / 13.085B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--
--2023/Q412.024B / 12.007B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 13.726B--
Nov 12, 20242024/Q3-- / 13.085B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--
--2023/Q412.024B / 12.007B--

Unlock Free Earnings Estimates

AstraZeneca Earnings Reports

  • 6-K: H1 and Q2 2024 Results

    Jul 25 09:09 ET

  • AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030

    May 21 06:10 ET

  • 6-K: Q1 2024 Results

    Apr 25 06:29 ET

  • AstraZeneca | 6-K: Closure of Notes Sale Pursuant to Underwriting Agreement

    Feb 26 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday-0.35%